|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 435.19 USD | +1.44% |
|
+0.48% | -6.78% |
| 04/05 | Argus Adjusts Price Target on HCA Healthcare to $500 From $560, Maintains Buy Rating | MT |
| 29/04 | Declaration of Voting Results by HCA Healthcare | CI |
Business description: HCA Healthcare, Inc.
At the end of 2025, the group operated 190 hospitals (including 179 general hospitals, 7 psychiatric hospitals and 4 rehabilitation hospitals) located in the United States (172) and the United Kingdom (8), as well as 121 surgery centers and 31 endoscopy centers in the United States.
Number of employees: 2,75,000
Sales by Activity: HCA Healthcare, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Operating Hospitals and Related Health Care Entities | 5.88TCr | 6.02TCr | 6.5TCr | 7.06TCr | 7.56TCr |
Geographical breakdown of sales: HCA Healthcare, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
American Group | 2.62TCr | 2.69TCr | 2.23TCr | 2.46TCr | 2.64TCr |
Atlantic Group | - | - | 2.12TCr | 2.32TCr | 2.47TCr |
National Group | 2.98TCr | 3.04TCr | 1.81TCr | 1.96TCr | 2.13TCr |
Corporate and Other | 277.4Cr | 301.8Cr | 337.8Cr | 321.7Cr | 316.8Cr |
Executive Committee: HCA Healthcare, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Samuel Hazen
CEO | Chief Executive Officer | 64 | 01/01/2019 |
Michael Marks
DFI | Director of Finance/CFO | 56 | 01/05/2024 |
Chad Wasserman
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2024 |
| Chief Administrative Officer | 62 | 01/04/2024 | |
Michael Cuffe
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/10/2011 |
Composition of the Board of Directors: HCA Healthcare, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Frist
CHM | Chairman | 58 | 26/04/2019 |
William Frist
BRD | Director/Board Member | 56 | 01/01/2009 |
Samuel Hazen
BRD | Director/Board Member | 64 | 10/09/2018 |
Wayne Riley
BRD | Director/Board Member | 66 | 01/01/2012 |
| Director/Board Member | 69 | 01/02/2014 | |
| Director/Board Member | 74 | 24/12/2010 | |
Hugh Johnston
BRD | Director/Board Member | 64 | 01/09/2021 |
Andrea Smith
BRD | Director/Board Member | 59 | 26/01/2022 |
John Chidsey
BRD | Director/Board Member | 63 | 15/07/2025 |
Holdings: HCA Healthcare, Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
ONDINE BIOMEDICAL INC. 8.15% | 4,22,72,654 | 8.15% | 6 M $ |
Company details: HCA Healthcare, Inc.
Other Healthcare Facilities & Services
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.44% | +0.48% | +22.96% | +56.67% | 9.65TCr | |
| +3.65% | +10.31% | +33.46% | +29.95% | 12TCr | |
| +0.54% | -0.70% | -4.48% | +61.01% | 2.72TCr | |
| -1.52% | -0.67% | +2.15% | +14.18% | 2.08TCr | |
| -1.81% | -2.74% | +6.53% | +39.09% | 2.07TCr | |
| +0.22% | -7.80% | -17.04% | -23.72% | 2.09TCr | |
| +1.51% | -0.16% | +13.68% | +61.58% | 1.72TCr | |
| -1.93% | +3.88% | +27.72% | +173.14% | 1.64TCr | |
| +1.22% | +30.99% | +38.31% | +122.68% | 1.28TCr | |
| +0.38% | -3.29% | -25.23% | -12.35% | 1.18TCr | |
| Average | +0.37% | +2.58% | +9.81% | +52.22% | 3.6TCr | |
| Weighted average by Cap. | +1.46% | +3.74% | +18.53% | +45.90% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCA Stock
- Company HCA Healthcare, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition